— Know what they know.
Not Investment Advice

CAMP NASDAQ

CAMP4 Therapeutics Corporation
1W: +2.0% 1M: +5.3% 3M: -6.5% YTD: -33.3% 1Y: +35.6%
$4.00
+0.16 (+4.17%)
 
Weekly Expected Move ±8.9%
$3 $4 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 38 · $251.0M mcap · 43M float · 0.573% daily turnover · Short 60% of daily vol

Balance Sheet Trends

Total Assets
$118M +50.4% ▲
5Y CAGR: -23.2%
Total Liabilities
$70M +362.3% ▲
5Y CAGR: -27.2%
Shareholders Equity
$48M -24.5% ▼
5Y CAGR: -13.6%
Cash & Investments
$110M +71.0% ▲
5Y CAGR: +3.6%
Total Debt
$2M -77.2% ▼
5Y CAGR: -60.7%
Net Debt
-$108M -94.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$91M$83M$38M$64M$110M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$91M$83M$38M$64M$110M
Net Receivables$59M$678K$442K$108K$155K
Inventory$20M$0$0$0$0
Other Current Assets$24M$205K$245K$211K$4M
Total Current Assets$194M$84M$40M$66M$114M
Property, Plant & Equip.$50M$17M$13M$10M$3M
Goodwill & Intangibles$127M$0$0$0$0
Long-Term Investments$24M$0$0$0$894K
Other Non-Current Assets$3M$1M$2M$2M$83K
Total Non-Current Assets$209M$18M$15M$12M$4M
Total Assets$402M$103M$55M$78M$118M
— Liabilities —
Accounts Payable$31M$2M$1M$1M$182K
Short-Term Debt$8M$0$0$0$286K
Deferred Revenue$32M$0$0$385K$9M
Other Current Liabilities$24M$2M$2M$3M$6M
Total Current Liabilities$95M$8M$8M$10M$16M
Long-Term Debt$201M$0$0$0$2M
Other Non-Current Liab.$11M$162M$162M$2K$45M
Total Non-Current Liabilities$227M$172M$171M$6M$55M
Total Liabilities$322M$180M$179M$15M$70M
— Equity —
Common Stock$359K$1K$1K$2K$6K
Retained Earnings-$157M-$111M-$160M-$212M-$292M
Accumulated OCI-$2M$0$0$0$0
Total Stockholders Equity$80M-$78M-$124M$63M$48M
Total Liabilities & Equity$402M$103M$55M$78M$118M
— Key Metrics —
Total Debt$209M$12M$12M$9M$2M
Net Debt$118M-$71M-$27M-$55M-$108M
Total Investments$24M$0$0$0$894K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms